Press
Release

Altimmune to Present at Upcoming Investor and Scientific Conferences

November 22, 2021 at 4:01 PM EST

GAITHERSBURG, Md., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following conferences:

  • Piper Sandler 33rd Annual Virtual Healthcare Conference
    November 29-December 2, 2021
    Webcast available now
  • 5th Annual NASH Summit 2021
    November 30, 2021
    9:00 am Eastern Time
  • 4th Annual Evercore ISI HealthCONx Conference
    December 2, 2021
    10:55 am Eastern Time

Presentation materials, including webcast links to the Piper Sandler and Evercore ISI presentations, will be accessible on the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Altimmune Investor & Media Contact:

Will Brown
Chief Financial Officer
Phone: 240-654-1450
wbrown@altimmune.com


Primary Logo

Source: Altimmune, Inc

 

Investor Contact

Will Brown
Chief Financial Officer

Email: wbrown@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe